# Evaluation the Safety of hemay005 Tablets

> **NCT06908642** · PHASE1 · COMPLETED · sponsor: **Anhui Hemay Pharmaceutical Co., Ltd** · enrollment: 468 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Hemay005 tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06908642
- **Lead sponsor:** Anhui Hemay Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-25
- **Primary completion:** 2025-06-03
- **Final completion:** 2025-06-03
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06908642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06908642, "Evaluation the Safety of hemay005 Tablets". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06908642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*